Josh Silverman

About

Josh Silverman, Ph.D., is the CEO and founder of Windfall Bio, which develops nature-based technology to convert methane into organic soil nutrients. He has more than 20 years of experience in biotech research and commercialization, previously serving as CEO of Aromyx, founder and CTO of Calysta, and VP of Drug Development at Amunix, and has advised several climate-focused biotech companies. He holds a B.Sc. in Molecular Biology from UC San Diego and a Ph.D. in Biochemistry from Stanford University.